Press release
European Interleukin Inhibitors Market Trends, Size, Competitive Analysis and Forecast 2021-2027
To Request a Sample of our Report on European Interleukin Inhibitors Market: https://www.omrglobal.com/request-sample/europe-interleukin-inhibitors-market
The prevalence of asthma in the region in 2017 was more than 40.3 million which increased to 41.4 million in 2019. Whereas, the prevalence of inflammatory bowel disease (IBD) in 2017 was 1.5 million in 2017 which increased to more than 1.6 million in 2019. Further, the well-established healthcare sector in the region creates scope for market growth. There has been increased adoption of interleukin inhibitors for the treatment of such diseases. The IL-17 inhibitors function as angiogenesis; have a pro-inflammatory role in asthma; increases the inflammatory cytokines; and induces production of IL-4, IL-5, and IL-13, which stimulate eosinophil expansion. Hence, this is likely to drive the market growth over the forecast period.
(Get 15% Discount on Buying this Report)
A full Report of European Interleukin Inhibitors Market is Available at: https://www.omrglobal.com/industry-reports/europe-interleukin-inhibitors-market
Market Coverage
• Market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- By Product Type and Applications
• Region Covered- Europe
• Competitive Landscape- Eli Lilly and Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck KGaA, AstraZeneca Plc, and Sun Pharmaceutical Industries Ltd. among others
European Interleukin Inhibitors Market – Segmentation
By Product Type
• IL-1 Inhibitors
• IL-5 Inhibitors
• IL-6 Inhibitors
• IL-17 Inhibitors
• IL-23 Inhibitors
By Applications
• Arthritis
• Asthma
• Eczema
• Inflammatory Bowel Disease (IBD)
• Psoriasis
• Others
European Interleukin Inhibitors Market – Countries Covered
• Europe
• UK
• Germany
• France
• Italy
• Spain
Rest of Europe
Company Profiles
• AbbVie, Inc.
• AstraZeneca Plc
• Bausch Health Co. Inc.
• Bristol–Myers Squibb Co.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson and Johnson Services Inc.
• Merck KgaA
• Novartis AG
• Regeneron Pharmaceuticals, Inc.
• Sanofi SA
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceuticals Industries, Ltd
• Valeant Pharmaceuticals, Inc.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/europe-interleukin-inhibitors-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release European Interleukin Inhibitors Market Trends, Size, Competitive Analysis and Forecast 2021-2027 here
News-ID: 2282082 • Views: …
More Releases from Orion Market Research
Engineered Wood Adhesives Market is Likely to Increase at a Significantly High C …
The global engineered wood adhesives market is anticipated to grow at a CAGR of 19.0% during the forecast period (2024-2031). The market growth is attributed to the growing preference towards engineered wood products in furniture, and buildings, like plywood, and particleboard with increased demand as these products' construction requires reliable adhesives globally. There are numerous applications for engineered wood adhesives. Wood adhesive products are used to bind wood fibers, strands, and particles…
Engineered Wood Adhesives Market is Likely to Increase at a Significantly High C …
The global engineered wood adhesives market is anticipated to grow at a CAGR of 19.0% during the forecast period (2024-2031). The market growth is attributed to the growing preference towards engineered wood products in furniture, and buildings, like plywood, and particleboard with increased demand as these products' construction requires reliable adhesives globally. There are numerous applications for engineered wood adhesives. Wood adhesive products are used to bind wood fibers, strands, and particles…
Engineered Wood Adhesives Market is Likely to Increase at a Significantly High C …
The global engineered wood adhesives market is anticipated to grow at a CAGR of 19.0% during the forecast period (2024-2031). The market growth is attributed to the growing preference towards engineered wood products in furniture, and buildings, like plywood, and particleboard with increased demand as these products' construction requires reliable adhesives globally. There are numerous applications for engineered wood adhesives. Wood adhesive products are used to bind wood fibers, strands, and particles…
Engineered Wood Adhesives Market is Likely to Increase at a Significantly High C …
The global engineered wood adhesives market is anticipated to grow at a CAGR of 19.0% during the forecast period (2024-2031). The market growth is attributed to the growing preference towards engineered wood products in furniture, and buildings, like plywood, and particleboard with increased demand as these products' construction requires reliable adhesives globally. There are numerous applications for engineered wood adhesives. Wood adhesive products are used to bind wood fibers, strands, and particles…
More Releases for Inhibitors
Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts…
Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market to Regist …
Vesicular monoamine transporter 2 (VMAT2) is a membrane-embedded protein that is responsible for uptake of monoamines neurotransmitters such as dopamine, serotonin, norepinephrine, and histamines into the synaptic vesicles in monoaminergic neurons. Vesicular monoamine transporter proteins 2 are expressed in the central nervous system (CNS) and plays the crucial role in the signaling process between the monoamine neurons. VMAT2 is the only transporter that carries the cytoplasmic dopamine into the vesicles.…
Crude Oil Flow Improvers Market by Type (Paraffin Inhibitors, Asphaltene Inhibit …
Global Crude Oil Flow Improvers Market was valued at $1,282 million in 2016, and is anticipated to reach $1,920 million, growing at a CAGR of 5.7% from 2017 to 2023. Crude oil is one of the most actively traded commodities with a stable growth rate globally. It is extracted from remote locations and needs to be transported through pipelines. Transportation of crude oil via pipeline is relatively difficult, owing to…
Immune Check Point Inhibitors Market Immune Check Point Inhibitors Clinical Pipe …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Immune Checkpoint Inhibitors- Introduction to Next Generation Cancer Immunotherapy
1.1 Overview
1.2 History- From Tragedy to Breakthrough
Major Immune Checkpoints Proteins
2.1 Role of Cytotoxic T lymphocyte Antigen-4 (CTLA-4) in Cancer Development
2.2 Role of Programed Cell Death Protein 1 (PD1) in Cancer Development
Mechanism of Action of Immune Checkpoint Inhibitors
3.1 Cytotoxic T lymphocyte Antigen-4…
Global Immune Check Point Inhibitors Market & Immune Check Point Inhibitors Clin …
Immunotherapy represents a paradigm shift in oncology therapy along the multiple fronts. Although, targeted therapy upgrades the underlying signaling defect which results in oncogenesis within the tumor. The immune checkpoint blockade is fundamentally a therapy which directed at the patient's native immune system to tilt the immune homeostasis away from self-tolerance towards cytotoxicity, with the goal of inducing antitumor immunity.
The immune checkpoint inhibitors such as ipilimumab, nivolumab and pembrolizumab…
Tumor Necrosis Factor Inhibitors Market & TNF Inhibitors Clinical Pipeline Outlo …
The search for the effective therapeutic approaches in the modulation of the TNF has been focus of the research efforts. Approximately 1 Million people in the worldwide either undergoing the treatment or have been treated with the TNF inhibitors which are available in the pharmaceutical market which surrounding the indications that include the rheumatoid arthritis, psoriatic arthritis, psoriasis and inflammatory bowel diseases.
The neutralization of the TNF signaling can be achieved…
